120 related articles for article (PubMed ID: 37788621)
1. Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States.
Joudrey PJ; Chen K; Oldfield BJ; Biegacki E; Fiellin DA
J Addict Med; 2023 Sep-Oct 01; 17(5):615-617. PubMed ID: 37788621
[TBL] [Abstract][Full Text] [Related]
2. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.
Joudrey PJ; Chadi N; Roy P; Morford KL; Bach P; Kimmel S; Wang EA; Calcaterra SL
Drug Alcohol Depend; 2020 Mar; 211():107968. PubMed ID: 32268248
[TBL] [Abstract][Full Text] [Related]
3. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States.
Kiang MV; Barnett ML; Wakeman SE; Humphreys K; Tsai AC
Drug Alcohol Depend; 2021 Nov; 228():109081. PubMed ID: 34600256
[TBL] [Abstract][Full Text] [Related]
4. Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.
Iloglu S; Joudrey PJ; Wang EA; Thornhill TA; Gonsalves G
Drug Alcohol Depend; 2021 Mar; 220():108534. PubMed ID: 33497963
[TBL] [Abstract][Full Text] [Related]
5. Community socioeconomic and urban-rural differences in emergency medical services times for suspected stroke in North Carolina.
Chari SV; Cui ER; Fehl HE; Fernandez AR; Brice JH; Patel MD
Am J Emerg Med; 2023 Jan; 63():120-126. PubMed ID: 36370608
[TBL] [Abstract][Full Text] [Related]
6. Demographic Disparities in Proximity to Certified Stroke Care in the United States.
Yu CY; Blaine T; Panagos PD; Kansagra AP
Stroke; 2021 Aug; 52(8):2571-2579. PubMed ID: 34107732
[TBL] [Abstract][Full Text] [Related]
7. Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study.
Cunningham CO; Zhang C; Hollins M; Wang M; Singh-Tan S; Joudrey PJ
BMC Public Health; 2022 Apr; 22(1):671. PubMed ID: 35387635
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban-rural differences.
Masiano SP; Martin EG; Bono RS; Dahman B; Sabik LM; Belgrave FZ; Adimora AA; Kimmel AD
J Int AIDS Soc; 2019 May; 22(5):e25286. PubMed ID: 31111684
[TBL] [Abstract][Full Text] [Related]
9. Community Socioeconomic and Urban-Rural Disparities in Prehospital Notification of Stroke by Emergency Medical Services in North Carolina.
Shams RB; Chari SV; Cui ER; Fernandez AR; Brice JH; Winslow JE; Jauch EC; Patel MD
South Med J; 2023 Sep; 116(9):765-771. PubMed ID: 37657786
[TBL] [Abstract][Full Text] [Related]
10. Travel Time to Radiation Oncology Facilities in the United States and the Influence of Certificate of Need Policies.
Herb JN; Wolff RT; McDaniel PM; Holmes GM; Royce TJ; Stitzenberg KB
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):344-351. PubMed ID: 32891795
[TBL] [Abstract][Full Text] [Related]
11. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment.
Burus T; VanHelene AD; Rooney MK; Lang Kuhs KA; Christian WJ; McNair C; Mishra S; Paulino AC; Smith GL; Frank SJ; Warner JL
JAMA Netw Open; 2024 May; 7(5):e2410670. PubMed ID: 38758559
[TBL] [Abstract][Full Text] [Related]
12. Access to community pharmacies based on drive time and by rurality across the contiguous United States.
Sharareh N; Zheutlin AR; Qato DM; Guadamuz J; Bress A; Vos RO
J Am Pharm Assoc (2003); 2024; 64(2):476-482. PubMed ID: 38215823
[TBL] [Abstract][Full Text] [Related]
13. Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.
Shah PD; Trogdon JG; Golden SD; Golin CE; Marciniak MW; Brewer NT
Milbank Q; 2018 Sep; 96(3):568-592. PubMed ID: 30203603
[TBL] [Abstract][Full Text] [Related]
14. Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior.
Mitchell P; Samsel S; Curtin KM; Price A; Turner D; Tramp R; Hudnall M; Parton J; Lewis D
Soc Sci Med; 2022 Jun; 302():114992. PubMed ID: 35512612
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.
Joudrey PJ; Kolak M; Lin Q; Paykin S; Anguiano V; Wang EA
JAMA Netw Open; 2022 Apr; 5(4):e227028. PubMed ID: 35438757
[TBL] [Abstract][Full Text] [Related]
16. Race/Ethnicity and Geographic Access to Urban Trauma Care.
Tung EL; Hampton DA; Kolak M; Rogers SO; Yang JP; Peek ME
JAMA Netw Open; 2019 Mar; 2(3):e190138. PubMed ID: 30848804
[TBL] [Abstract][Full Text] [Related]
17. Geographic access to buprenorphine prescribers for patients who use public transit.
Drake C; Donohue JM; Nagy D; Mair C; Kraemer KL; Wallace DJ
J Subst Abuse Treat; 2020 Oct; 117():108093. PubMed ID: 32811632
[TBL] [Abstract][Full Text] [Related]
18. Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona.
Brady BR; Gildersleeve R; Koch BD; Campos-Outcalt DE; Derksen DJ
Health Serv Insights; 2021; 14():11786329211037502. PubMed ID: 34408434
[TBL] [Abstract][Full Text] [Related]
19. Spatial availability of federally qualified health centers and disparities in health services utilization in medically underserved areas.
Lee EK; Donley G; Ciesielski TH; Freedman DA; Cole MB
Soc Sci Med; 2023 Jul; 328():116009. PubMed ID: 37301106
[TBL] [Abstract][Full Text] [Related]
20. A Geospatial Analysis of Factors Affecting Access to CT Facilities: Implications for Lung Cancer Screening.
Tailor TD; Tong BC; Gao J; Choudhury KR; Rubin GD
J Am Coll Radiol; 2019 Dec; 16(12):1663-1668. PubMed ID: 31302055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
